Gut health Medicines Approved in the EU (EMA)

• 22medicines authorised in the EU (authorised now)

Each number has its full source under its own list below.

• 19Sep2024

  Vyloy

  Active substance: zolbetuximab

  EMEA/H/C/005868
• 18Nov2021

  Qinlock

  Active substance: ripretinib

  EMEA/H/C/005614
• 11Feb2021

  Sunitinib Accord

  Active substance: sunitinib

  EMEA/H/C/005419
• 24Sep2020

  Ayvakyt

  Active substance: avapritinib

  EMEA/H/C/005208
• 26Sep2017

  Lutathera

  Active substance: lutetium (177Lu) oxodotreotide

  EMEA/H/C/004123
• 8Dec2016

  SomaKit TOC

  Active substance: edotreotide

  EMEA/H/C/004140
• 15Sep2016

  Sialanar

  Active substance: glycopyrronium bromide

  EMEA/H/C/003883
• 19Dec2014

  Cyramza

  Active substance: ramucirumab

  EMEA/H/C/002829
• 12Sep2013

  Orphacol

  Active substance: cholic acid

  EMEA/H/C/001250
• 26Aug2013

  Nexium Control

  Active substance: esomeprazole

  EMEA/H/C/002618
• 26Aug2013

  Stivarga

  Active substance: regorafenib

  EMEA/H/C/002573
• 2Aug2009

  Afinitor

  Active substance: everolimus

  EMEA/H/C/001038
• 23Jul2009

  Vedrop

  Active substance: tocofersolan

  EMEA/H/C/000920
• 12Jun2009

  Somac Control

  Active substance: pantoprazole

  EMEA/H/C/001098
• 11Jun2009

  Pantozol Control

  Active substance: pantoprazole

  EMEA/H/C/001013

Source: European Medicines Agency, Centrally authorised human medicines (EPAR), authorised now. Retrieved 12 Nov 2026.

• Infectious diseases
• OTC medicines
• Autoimmune diseases
• Biologics and biosimilars
• Respiratory
• Allergies
• Pediatric
• Oncology